select whether the correct answer is a, b, c, or d
Burlington Medical Corporation Consolidated Statements of Financial Position December 31, 2017 2018 (In Millions) Assets: Current assets 4,187 Cash and cash equivalents 4,260 $ 521 Short-term investments 840 2,400 Accounts and notes receivable 3,404 410 Inventories, at cost 446 1,200 1,690 Prepaid expense and other current assets 8,718 Total current assets 10,640 - X Data Table cial state ed baland o,TTO TO,040 dington M earest wh Property and equipment, net 936 1,533 Investments 5,300 6,809 315 166 Other non-current assets 19,297 $ 15,120 Total assets Liabilities and stockholder's equity: Current liabilities Accounts payable 7,703 $ 6,006 Accrued and other liabilities 3,696 3,011 Total current liabilities 11,399 9,017 Long-term debt 301 302 Other non-current liabilities 1,689 1,180 Total liabilities 13,389 10,499 Stockholders' equity Preferred stock and capital in excess of $0.02 par value; shares issued and outstanding: none Common stock and capital in excess of $0.05 par value; shares authorized: 6,000; shares issued: 2,681 and 2,424, respectively 7,820 7,004 Treasury stock, at cost; 184 and 127 shares, respectively (6,200) (4,414) Retained earnings 4,422 2,105 Other comprehensive loss (102) (32) Other (32) (42) Total stockholders' equity 5,908 4,621 Total liabilities and stockholders' equity $ 19,297 S 15,120 Burlington Medical Corporation Consolidated Statements of Income Year ended December 31, 2018 2017 2016 (In Millions, Except per Share Amounts) Net revenue 42,199 $ 35,613 $ 31,125 33,792 29,275 Cost of goods sold 25,412 Gross profit 8,407 6,338 5,713 Operating expenses: Selling, general, and administrative 3,400 3,260 2,600 Research, development, and engineerina. 588 dical's days' sales in receivables during 2018 was le milion ar intermediary ratios to two decimal places, XXX) X i Data Table 2,600 3,260 3,400 Selling, general, and administrative 533 554 Research, development, and engineering 588 506 Special charges 3,639 3,988 3,814 Total operating expenses Operating income 2,074 4,419 2,524 160 225 (32) Investment and other income (loss), net Income before income taxes 4,579 2,749 2,042 Income tax expense 1,128 945 480 S 3,451 $ Net income 1,804 $ 1,562 The Burlington Medical Corporation financial statements follow: (Click the icon to view the consolidated balance sheets.) (Click the icon to view the consolidated income statemer Assuming all sales were on account, Burlington Medical's days' sales in receivables during 2018 was (Round intermediary calculation to the nearest whole million and intermediary ratios to two decimal places, X.XX.) O A. 25 days. O B. 15.4 days O C. 35 days O D. 133.0 days
